Y Intercept Hong Kong Ltd Invests $258,000 in Addus HomeCare Co. (NASDAQ:ADUS)

Y Intercept Hong Kong Ltd purchased a new stake in Addus HomeCare Co. (NASDAQ:ADUS) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,059 shares of the company’s stock, valued at approximately $258,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ADUS. Quarry LP purchased a new position in shares of Addus HomeCare in the 3rd quarter valued at $28,000. Farther Finance Advisors LLC increased its holdings in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares in the last quarter. KBC Group NV raised its position in Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares during the period. Assetmark Inc. lifted its stake in shares of Addus HomeCare by 11.5% during the third quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock worth $156,000 after purchasing an additional 121 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Addus HomeCare by 34.5% in the fourth quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock worth $158,000 after buying an additional 323 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently commented on ADUS shares. Macquarie reissued an “outperform” rating and set a $129.00 price target on shares of Addus HomeCare in a research report on Thursday, February 27th. Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Finally, Stephens dropped their target price on Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $132.78.

Insiders Place Their Bets

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $93.99 on Wednesday. The stock has a 50-day simple moving average of $121.21 and a 200 day simple moving average of $125.59. Addus HomeCare Co. has a one year low of $87.88 and a one year high of $136.72. The company has a market capitalization of $1.71 billion, a price-to-earnings ratio of 21.51, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. On average, equities research analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.